Pharmaceutical Market Access in Emerging Markets

Nonfiction, Health & Well Being, Medical, Reference, Public Health, Business & Finance, Marketing & Sales
Cover of the book Pharmaceutical Market Access in Emerging Markets by Güvenç Koçkaya, Albert Wertheimer, SEEd Edizioni Scientifiche
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Güvenç Koçkaya, Albert Wertheimer ISBN: 9788897419648
Publisher: SEEd Edizioni Scientifiche Publication: October 27, 2016
Imprint: Language: English
Author: Güvenç Koçkaya, Albert Wertheimer
ISBN: 9788897419648
Publisher: SEEd Edizioni Scientifiche
Publication: October 27, 2016
Imprint:
Language: English

The definition of Market Access was first reported by the World Trade Organization as “to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade”. Pharmaceutical Market Access is different and could be: achieving the optimal price for a product or service and/or maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, since it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement.
Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. It was reported that CAGR was 6.0% in the period 2011-2017, and expected sales exceeding 1.1 trillion USD by 2017 for emerging countries. Furthermore, CAGR 2008-2012 for recently launched pharmaceuticals were 9.8% for emerging countries and 1.5% for the top 8 developed countries.
The Market Access processes in the most important emerging countries in the selected regions are defined in this book with the aim to help local experts, local government officers, headquarter managements, and everyone who want to learn more about healthcare system and health policies pathways of Market Access, mapping and structure of decision makers, challenges and catalyzers for Market Access in the emerging countries.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The definition of Market Access was first reported by the World Trade Organization as “to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade”. Pharmaceutical Market Access is different and could be: achieving the optimal price for a product or service and/or maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, since it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement.
Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. It was reported that CAGR was 6.0% in the period 2011-2017, and expected sales exceeding 1.1 trillion USD by 2017 for emerging countries. Furthermore, CAGR 2008-2012 for recently launched pharmaceuticals were 9.8% for emerging countries and 1.5% for the top 8 developed countries.
The Market Access processes in the most important emerging countries in the selected regions are defined in this book with the aim to help local experts, local government officers, headquarter managements, and everyone who want to learn more about healthcare system and health policies pathways of Market Access, mapping and structure of decision makers, challenges and catalyzers for Market Access in the emerging countries.

More books from SEEd Edizioni Scientifiche

Cover of the book Tromboembolia polmonare acuta by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Paediatric Hypertension (includes downloadable software) by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Unusual Signs and Symptoms in Internal Medicine by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Translating Clinical Trial Outcomes Measures by Güvenç Koçkaya, Albert Wertheimer
Cover of the book La comunicazione motivante nella terapia di sovrappeso e obesità by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Prescrizione off-label. Normative e applicazioni by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Drugs and Laboratory Parameters by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Chemotherapy regimens in rare solid tumors by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Farmacoeconomia in pratica by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Farmacoeconomia by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Farmacologia di Genere by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Ginecologia e attività fisica by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Migliorare la compliance. L'utilità del colloquio motivazionale by Güvenç Koçkaya, Albert Wertheimer
Cover of the book La certificazione di malattia del medico di famiglia by Güvenç Koçkaya, Albert Wertheimer
Cover of the book Ipertensione in pediatria (include software scaricabile) by Güvenç Koçkaya, Albert Wertheimer
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy